DOACs vs Warfarin for Post-myocardial Infarction Left Ventricular Thrombus: A GRADE-assessed Meta-Analysis With Trial Sequential Analysis of Randomized Trials
Background and Purpose Current AHA and ACC guidelines warrant studies comparing direct oral anticoagulant (DOAC) and warfarin for post-myocardial infarction (MI) left ventricular thrombus (LVT). DOAC is increasingly considered due to its minimal monitoring requirement. However, DOAC efficacy in LVT...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2026-07-01
|
| シリーズ: | Clinical and Applied Thrombosis/Hemostasis |
| オンライン・アクセス: | https://doi.org/10.1177/10760296261468457 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
